Last quarter (Q2 2022), Sino Biopharmaceutical's total revenue was ¥―, a decrease of -100.00% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was ¥―. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	¥ 5.52B	¥ 26.86B	¥ 23.65B	¥ 24.23B	¥ 20.89B	¥ 14.82B
Cost of Revenue	¥ 1.11B	¥ 5.33B	¥ 5.18B	¥ 4.93B	¥ 4.20B	¥ 3.09B
Gross Profit	¥ 4.41B	¥ 21.53B	¥ 18.46B	¥ 19.31B	¥ 16.69B	¥ 11.73B
Operating Expense	¥ 3.55B	¥ 17.19B	¥ 14.05B	¥ 13.94B	¥ 12.12B	¥ 8.46B
Operating Income	¥ 866.85M	¥ 4.34B	¥ 4.42B	¥ 5.36B	¥ 4.57B	¥ 3.27B
Net Non Operating Interest Income Expense	¥ -71.16M	¥ -146.56M	¥ -129.37M	¥ 27.76M	¥ 9.46M	¥ 5.11M
Other Income Expense	-	-	-	-	-	-
Pretax Income	¥ 1.27B	¥ 18.57B	¥ 5.01B	¥ 5.69B	¥ 11.43B	¥ 4.20B
Tax Provision	¥ -105.31M	¥ 1.96B	¥ 672.38M	¥ 902.75M	¥ 696.24M	¥ 542.29M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	¥ 920.59M	¥ 14.61B	¥ 2.77B	¥ 2.76B	¥ 9.05B	¥ 2.17B
Basic EPS	¥ 0.05	-	¥ 0.15	¥ 0.14	¥ 0.49	¥ 0.13
Diluted EPS	¥ 0.05	-	¥ 0.15	¥ 0.14	¥ 0.49	¥ 0.13
Basic Average Shares	¥ 18.58B	-	¥ 18.80B	¥ 18.81B	¥ 18.55B	¥ 16.68B
Diluted Average Shares	¥ 18.58B	-	¥ 18.80B	¥ 18.81B	¥ 18.55B	¥ 16.68B
Dividend Per Share	¥ 0.02	-	¥ 0.03	¥ 0.04	¥ 0.03	¥ 0.02
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	¥ <0.01	-	¥ 0.17	¥ 0.17	¥ 0.15	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	¥ 4.65B	¥ 22.52B	¥ 19.23B	¥ 18.87B	¥ 16.32B	¥ 11.55B
Net Income From Continuing And Discontinued Operation	¥ 920.59M	¥ 14.61B	¥ 2.77B	¥ 2.76B	¥ 9.05B	¥ 2.17B
Normalized Income	¥ 589.75M	¥ 14.59B	¥ 2.40B	¥ 2.76B	¥ 2.84B	¥ 2.08B
Interest Expense	¥ 57.91M	¥ 308.62M	¥ 323.37M	¥ 229.95M	¥ 153.26M	¥ 77.94M
EBIT	¥ 1.33B	¥ 18.88B	¥ 5.34B	¥ 5.92B	¥ 11.58B	¥ 4.27B
EBITDA	¥ 1.33B	¥ 19.87B	¥ 6.99B	¥ 7.37B	¥ 12.76B	¥ 4.62B

Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing